Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

75.60p
   
  • Change Today:
    -6.40p
  • 52 Week High: 87.50p
  • 52 Week Low: 63.00p
  • Currency: UK Pounds
  • Shares Issued: 529.49m
  • Volume: 1,546,477
  • Market Cap: 400.29m
  • RiskGrade: 154

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 75.60p per share. In the last year Alliance Pharma's share price has ranged from 63.00p to 87.50p and brokers are currently rating this stock as 'buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 1.9% 1.8%
Div Cover 3.1 3.1
Op Mrgn 20.0% 22.7%
ROCE 60.6%  
Latest F'cast
P/E 16.7 15.1
PEG n/a 1.4
Pr/Revenue 3.4 2.8
Pr/Book 1.6  
Latest F'cast
Revenue 16.3% 22.1%
PBT -19.4% 43.5%
EPS -14.8% 10.4%
DPS 10.0% 9.1%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 144.30 32.73 5.01p 15.1 1.4 +10% 1.60p 1.8%
31-Dec-20 151.35 35.83 5.44p 13.9 1.6 +8% 1.76p 2.0%
31-Dec-21 158.26 38.69 5.91p 12.8 1.5 +9% 1.90p 2.2%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

NOTIFICATION OF MAJOR HOLDINGS 04-Feb-2020 16:45 RNS
Total Voting Rights 03-Feb-2020 17:13 RNS
Notification of Major Holdings 22-Jan-2020 12:04 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 75.60p
Change Today -6.40p
% Change -7.80 %
52 Week High 87.50p
52 Week Low 63.00p
Volume 1,546,477
Shares Issued 529.49m
Market Cap 400.29m
RiskGrade 154

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.15% below the market average14.15% below the market average14.15% below the market average14.15% below the market average14.15% below the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Price Trend
72.50% above the market average72.50% above the market average72.50% above the market average72.50% above the market average72.50% above the market average
67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average
Income
54.9% below the market average54.9% below the market average54.9% below the market average54.9% below the market average54.9% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
0.13% below the market average0.13% below the market average0.13% below the market average0.13% below the market average0.13% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Dec-19 13-Jun-19
Paid 10-Jan-20 11-Jul-19
Amount 0.54p 0.98p

Trades for 28-Feb-2020

Time Volume / Share Price
16:35 256,619 @ 75.60p
16:29 64,000 @ 74.00p
16:29 2,000 @ 75.00p
16:29 1,482 @ 75.00p
16:29 176 @ 75.00p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page